Gentamicin 10 mg/ml solution for injection or infusion Irlanda - inglês - HPRA (Health Products Regulatory Authority)

gentamicin 10 mg/ml solution for injection or infusion

pinewood laboratories ltd - gentamicin - solution for injection/infusion - 10 milligram(s)/millilitre - other aminoglycosides; gentamicin

Gentamicin 40 mg/ml solution for injection or infusion Irlanda - inglês - HPRA (Health Products Regulatory Authority)

gentamicin 40 mg/ml solution for injection or infusion

pinewood laboratories ltd - gentamicin - solution for injection/infusion - 40 milligram(s)/millilitre - other aminoglycosides; gentamicin

Dobutamine-hameln 12.5 mg/ml concentrate for solution for infusion Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

dobutamine-hameln 12.5 mg/ml concentrate for solution for infusion

max health limited - dobutamine hydrochloride 14 mg/ml equivalent to dobutamine 12.5 mg/ml, 250 mg dobutamine in 20 ml;   - concentrate for infusion - 12.5 mg/ml - active: dobutamine hydrochloride 14 mg/ml equivalent to dobutamine 12.5 mg/ml, 250 mg dobutamine in 20 ml   excipient: hydrochloric acid sodium metabisulfite water for injection - dobutamine hydrochloride is indicated when inotropic support is necessary for the treatment of patients with hypoperfusion states in whom cardiac output is insufficient to meet circulatory demands. dobutamine hydrochloride is also indicated when inotropic support is required for the treatment of patients in whom abnormally increased ventricular filling pressures introduce the risk of pulmonary congestion and oedema. conditions which may precipitate such situations include the following hypoperfusion states: initially cardiac in origin: a. acute heart failure acute myocardial infarction, cardiogenic shock, following cardiac surgery, medicine-induced depression of cardiac contractility such as that which occurs in excessive ?-adrenergic receptor blockade. b. chronic heart failure acute decompensation of chronic congestive heart failure, temporary inotropic support in advanced chronic congestive heart failure, as an adjunct to therapy with conventional oral inotropic agents, systemic vasodilators, and diuretics. initially noncardiac in origin: acute hypoperfusion states secondary to trauma, surgery, sepsis, or hypovolaemia when mean arterial pressure is above 70-mm hg and pulmonary capillary wedge pressure is 18-mm hg or greater, with inadequate response to volume repletion and increased ventricular filling pressure, low cardiac output secondary to mechanical ventilation with positive end-expiratory pressure (peep). paediatric population: dobutamine is indicated in all paediatric age groups (from neonates to 18 years of age) as inotropic support in low cardiac output hypoperfusion states resulting from decompensated heart failure, following cardiac surgery, cardiomyopathies and in cardiogenic or septic shock. dobutamine stress echocardiography: dobutamine hydrochloride may be used as a substitute for physical exercise in stress testing in the diagnosis of coronary artery disease. precautions apply (refer to data sheet).

Gentamicin 40mg/ml Solution for Injection or Infusion Reino Unido - inglês - myHealthbox

gentamicin 40mg/ml solution for injection or infusion

wockhardt uk ltd - gentamicin sulfate - solution for injection or infusion - 40mg/ml - antibacterial for systemic use - it is indicated in bacteraemia, urinary tract infections, chest infections, severe neonatal infections and other serious systemic infections due to susceptible organisms, in adults and children including neonates

Gentamicin 10mg/ml Solution for Injection or Infusion Reino Unido - inglês - myHealthbox

gentamicin 10mg/ml solution for injection or infusion

wockhardt uk ltd - gentamicin sulfate - solution for injection or infusion - 10 mg/ml - antibacterial for systemic use - it is indicated in bacteraemia, urinary tract infections, chest infections, severe neonatal infections and other serious systemic infections due to susceptible organisms, in adults and children including neonates.